The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1289-1302.e4, December 2009

Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome

  • Karin R. Engelhardt, Dr

      Affiliations

    • Department of Immunology and Molecular Pathology, Royal Free Hospital and University College London, London, UK
    • These authors contributed equally to this work.
  • ,
  • Sean McGhee, MD

      Affiliations

    • Division of Immunology, Allergy and Rheumatology, Department of Pediatrics, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, Calif
    • These authors contributed equally to this work.
  • ,
  • Sabine Winkler, MSc

      Affiliations

    • Department of Immunology and Molecular Pathology, Royal Free Hospital and University College London, London, UK
  • ,
  • Atfa Sassi, PhD

      Affiliations

    • Laboratoire d'immunologie, vaccinologie et génétique moléculaire, Institut Pasteur de Tunis, Tunisia
  • ,
  • Cristina Woellner, MSc

      Affiliations

    • Department of Immunology and Molecular Pathology, Royal Free Hospital and University College London, London, UK
  • ,
  • Gabriela Lopez-Herrera, PhD

      Affiliations

    • Department of Immunology and Molecular Pathology, Royal Free Hospital and University College London, London, UK
  • ,
  • Andrew Chen

      Affiliations

    • Division of Immunology, Allergy and Rheumatology, Department of Pediatrics, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, Calif
  • ,
  • Hong Sook Kim, PhD

      Affiliations

    • Division of Immunology, Allergy and Rheumatology, Department of Pediatrics, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, Calif
  • ,
  • Maria Garcia Lloret, MD

      Affiliations

    • Division of Immunology, Allergy and Rheumatology, Department of Pediatrics, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, Calif
  • ,
  • Ilka Schulze, MD

      Affiliations

    • Center of Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg, Germany
  • ,
  • Stephan Ehl, MD

      Affiliations

    • Center of Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg, Germany
  • ,
  • Jens Thiel, MD

      Affiliations

    • Center of Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg, Germany
  • ,
  • Dietmar Pfeifer, Dr

      Affiliations

    • Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
  • ,
  • Hendrik Veelken, MD

      Affiliations

    • Department of Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
  • ,
  • Tim Niehues, MD

      Affiliations

    • HELIOS Klinikum Krefeld, Zentrum für Kinder-und Jugendmedizin, Krefeld, Germany
  • ,
  • Kathrin Siepermann, MD

      Affiliations

    • HELIOS Klinikum Krefeld, Zentrum für Kinder-und Jugendmedizin, Krefeld, Germany
  • ,
  • Sebastian Weinspach, MD

      Affiliations

    • Department of Pediatric Oncology, Hematology and Clinical Immunology, Center of Child and Adolescent Medicine, Heinrich-Heine-University Dusseldorf, Duesseldorf, Germany
  • ,
  • Ismail Reisli, MD

      Affiliations

    • Selcuk University, Division of Pediatric Allergy and Immunology, Konya, Turkey
  • ,
  • Sevgi Keles, MD

      Affiliations

    • Selcuk University, Division of Pediatric Allergy and Immunology, Konya, Turkey
  • ,
  • Ferah Genel, MD

      Affiliations

    • Behcet Uz State Hospital Division of Pediatric Immunology, Izmir, Turkey
  • ,
  • Necil Kutuculer, MD

      Affiliations

    • Ege University Faculty of Medicine, Department of Pediatrics, Izmir, Turkey
  • ,
  • Yıldız Camcıoğlu, MD

      Affiliations

    • Division of Pediatric Allergy-Immunology and Infectious Diseases, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
  • ,
  • Ayper Somer, MD

      Affiliations

    • Division of Infectious Diseases and Immunology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
  • ,
  • Elif Karakoc-Aydiner, MD

      Affiliations

    • Division of Pediatric Allergy and Immunology, Marmara University, Istanbul, Turkey
  • ,
  • Isil Barlan, MD

      Affiliations

    • Division of Pediatric Allergy and Immunology, Marmara University, Istanbul, Turkey
  • ,
  • Andrew Gennery, MD

      Affiliations

    • Institute of Cellular Medicine, Child Health, University of Newcastle Upon Tyne, Newcastle upon Tyne, UK
  • ,
  • Ayse Metin, MD, PhD

      Affiliations

    • Pediatric Immunology Unit, SB Ankara Diskapi Children's Hospital, Ankara, Turkey
  • ,
  • Aydan Degerliyurt, MD

      Affiliations

    • Pediatric Immunology Unit, SB Ankara Diskapi Children's Hospital, Ankara, Turkey
  • ,
  • Maria C. Pietrogrande, MD

      Affiliations

    • Department of Maternal and Pediatric Sciences, University of Milan, Fondazione IRCCS Policlinico Milano, Milan, Italy
  • ,
  • Mehdi Yeganeh, MD

      Affiliations

    • Immunology Asthma and Allergy Research Institute, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  • ,
  • Zeina Baz, MD

      Affiliations

    • Department of Pediatrics, St George Hospital University Medical Center, Beirut, Lebanon
  • ,
  • Salem Al-Tamemi, MD

      Affiliations

    • Department of Pediatrics, Sultan Qaboos University, Muscat, Oman
  • ,
  • Christoph Klein, MD, PhD

      Affiliations

    • Department of Pediatric Hematology/Oncology, Hannover Biomedical Research School, Hannover, Germany
  • ,
  • Jennifer M. Puck, MD

      Affiliations

    • University of California, San Francisco, Calif
  • ,
  • Steven M. Holland, MD

      Affiliations

    • Laboratory of Clinical Infectious Diseases, NIAID, NIH, Bethesda, Md
  • ,
  • Edward R.B. McCabe, MD, PhD

      Affiliations

    • Departments of Pediatrics, Human Genetics, and Bioengineering, and the Center for Society and Genetics, UCLA, Los Angeles, Calif
  • ,
  • Bodo Grimbacher, MD

      Affiliations

    • Department of Immunology and Molecular Pathology, Royal Free Hospital and University College London, London, UK
    • These authors contributed equally to this work.
    • Corresponding Author InformationReprint requests: Bodo Grimbacher, MD, Department of Immunology and Molecular Pathology, Royal Free Hospital and University College London, Pond Street, London NW3 2QG, United Kingdom.
  • ,
  • Talal A. Chatila, MD, MSc

      Affiliations

    • Division of Immunology, Allergy and Rheumatology, Department of Pediatrics, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, Calif
    • These authors contributed equally to this work.
    • Corresponding Author InformationTalal Chatila, MD, MSc, Division of Pediatric, Immunology, Allergy and Rheumatology, MDCC 12-430, Mail Code 175217, David Geffen School of Medicine, University of California at Los Angeles, 10833 Le Conte Avenue Los Angeles, CA 90095-1752.

Received 23 September 2009; received in revised form 22 October 2009; accepted 26 October 2009.

Background

The genetic etiologies of the hyper-IgE syndromes are diverse. Approximately 60% to 70% of patients with hyper-IgE syndrome have dominant mutations in STAT3, and a single patient was reported to have a homozygous TYK2 mutation. In the remaining patients with hyper-IgE syndrome, the genetic etiology has not yet been identified.

Objectives

We aimed to identify a gene that is mutated or deleted in autosomal recessive hyper-IgE syndrome.

Methods

We performed genome-wide single nucleotide polymorphism analysis for 9 patients with autosomal-recessive hyper-IgE syndrome to locate copy number variations and homozygous haplotypes. Homozygosity mapping was performed with 12 patients from 7 additional families. The candidate gene was analyzed by genomic and cDNA sequencing to identify causative alleles in a total of 27 patients with autosomal-recessive hyper-IgE syndrome.

Results

Subtelomeric biallelic microdeletions were identified in 5 patients at the terminus of chromosome 9p. In all 5 patients, the deleted interval involved dedicator of cytokinesis 8 (DOCK8), encoding a protein implicated in the regulation of the actin cytoskeleton. Sequencing of patients without large deletions revealed 16 patients from 9 unrelated families with distinct homozygous mutations in DOCK8 causing premature termination, frameshift, splice site disruption, and single exon deletions and microdeletions. DOCK8 deficiency was associated with impaired activation of CD4+ and CD8+T cells.

Conclusion

Autosomal-recessive mutations in DOCK8 are responsible for many, although not all, cases of autosomal-recessive hyper-IgE syndrome. DOCK8 disruption is associated with a phenotype of severe cellular immunodeficiency characterized by susceptibility to viral infections, atopic eczema, defective T-cell activation and Th17 cell differentiation, and impaired eosinophil homeostasis and dysregulation of IgE.

Key words: Autosomal recessive hyper-IgE syndrome, human gene mutation, DOCK8, primary immunodeficiency, molluscum contagiosum, recurrent infection, T cells, TH17 cells, eosinophils, IgE regulation, copy number variations, genomic deletions

Abbreviations used: AR, Autosomal-recessive, CFSE, Carboxyfluorescein succinimidyl ester, CNV, Copy number variation, DHR, Dedicator of cytokinesis homology region, DOCK, Dedicator of cytokinesis, GEF, Guanine nucleotide exchange factor, HIES, Hyper-IgE syndrome, NIH, National Institutes of Health, NK, Natural killer, STAT3, Signal transducer and activator of transcription 3, WASP, Wiskott-Aldrich syndrome protein

 

 Supported by National Institutes of Health grants 5R01AI065617 and 1R21AI087627 to T.C. and by the EU Marie-Curie grant MEXT-CT-2006-042316 and the European Community's 7th Framework Programme FP7/2007-2013 grant EURO-PADnet HEALTH-F2-2008-201549 to B.G.

 Disclosure of potential conflict of interest: K. R. Engelhardt, S. Winkler, and G. Lopez-Herrera are employed on a research grant from the European Union (EU Marie-Curie grant). S. McGhee is a board member of Madison's Foundation. E. R. B. McCabe has received research support from the National Institutes of Health/National Human Genome Research Institute. B. Grimbacher (EU Marie-Curie grant) has received research support from the European Union and the Primary Immunodeficiency Association. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(09)01604-2

doi:10.1016/j.jaci.2009.10.038

The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1289-1302.e4, December 2009